Lv1
50 积分 2026-01-10 加入
Peripheral Immune-Inflammatory Parameters in Parkinson’s Disease. Dependence on the Stage of Progression
22天前
已完结
Peripheral B cells altered in Parkinson disease
24天前
已完结
Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next Generation
1个月前
已完结
Safety and Efficacy of Anti-CD19/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor-Natural Killer Cell (CAR-NK) Therapy in Pediatric Patients with Refractory Systemic Lupus Erythematosus (SLE): A Preliminary Clinical Study
2个月前
已完结
Safety and Efficacy of Anti-CD19/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor-Natural Killer Cell (CAR-NK) Therapy in Pediatric Patients with Refractory Systemic Lupus Erythematosus (SLE): A Preliminary Clinical Study
2个月前
已关闭
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
2个月前
已完结
[Research progress of traditional Chinese medicine formula in treating allergic rhinitis]
2个月前
已完结
B cell-targeted therapies in systemic lupus erythematosus: Current status and perspectives
3个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
3个月前
已完结
Cytokine-induced memory-like natural killer cells in systemic lupus erythematosus patients
3个月前
已完结
皖公网安备34019202002308
